cro.directory
← Compare landing

AAVATAR Therapeutics vs uBriGene

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/en-aavatartps/ubrigene

CategoryAAVATAR TherapeuticsuBriGene
Listed sitecroboth
SummaryAAVATAR Therapeutics is an innovative gene therapy company developing a next-generation intelligent gene therapy platform.uBriGene is a global leader in advanced therapy medicinal products (ATMPs), cell and gene therapy CDMO services, and analytical testing. Headquartered in Maryland with operations across North America and Asia, the company specializes in bridging ATMP concepts from early…
Services
  • Translational Research
  • Discovery Research
  • Analytical Method Development & Validation
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Translational Research
Modalities
  • Gene Therapy
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
IndicationsData not yet provided.
  • Oncology
Locations
  • Headquarters, Seoul, Seoul, Republic of Korea
  • BRA, Seoul, Gangdong-gu, Republic of Korea
  • HQ, Hanam-si, Gyeonggi-do, Republic of Korea
  • Headquarters, Maryland, Maryland, USA
  • Boston, Boston, Massachusetts, USA
  • Worcester, Worcester, Massachusetts, USA
CertificationsData not yet provided.
  • FDA · Identifier: 20+ INDs filed and accepted
  • EMA · Identifier: 20+ INDs filed and accepted
  • NMPA · Identifier: 20+ INDs filed and accepted
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.